Literature DB >> 32007496

Two types of recessive hereditary spastic paraplegia in Roma patients in compound heterozygous state; no ethnically prevalent variant found.

Anna Uhrova Meszarosova1, Pavel Seeman2, Jan Jencik2, Jana Drabova3, Renata Cibochova4, Julia Stellmachova5, Dana Safka Brozkova2.   

Abstract

Hereditary spastic paraplegia (HSP or SPG) is a group of rare upper motor neuron diseases. As some ethnically-specific, disease-causing homozygous variants were described in the Czech Roma population, we hypotesised that some prevalent HSP-causing variant could exist in this population. Eight Czech Roma patients were found in a large group of Czech patients with suspected HSP and were tested using gene panel massively parallel sequencing (MPS). Two of the eight were diagnosed with SPG11 and SPG77, respectively. The SPG77 patient manifests a pure HSP phenotype, which is unusual for this SPG type. Both patients are compound heterozygotes for two different variants in the SPG11 (c.1603-1G>A and del ex. 16-18) and FARS2 (c.1082C>T and del ex.1-2) genes respectively; the three variants are novel. In order to find a potential ethnically-specific, disease-causing variant for HSP, we tested the heterozygote frequency of these variants among 130 anonymised DNA samples of Czech Roma individuals without clinical signs of HSP (HPS-negative). A novel deletion of ex.16-18 in the SPG11 gene was found in a heterozygous state in one individual in the HSP-negative group. Haplotype analysis showed that this individual and the patient with SPG11 shared the same haplotype. This supports the assumption that the identified SPG11 deletion could be a founder mutation in the Czech Roma population. In some Roma patients the disease may also be caused by two different biallelic pathogenic mutations.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Czech Roma population; Hereditary spastic paraplegia; Prevalent variant; SPG11; SPG77

Mesh:

Substances:

Year:  2020        PMID: 32007496     DOI: 10.1016/j.neulet.2020.134800

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  Neuropathy-associated Fars2 deficiency affects neuronal development and potentiates neuronal apoptosis by impairing mitochondrial function.

Authors:  Xihui Chen; Fangfang Liu; Bowen Li; Yufeng Wang; Lijuan Yuan; Anan Yin; Qi Chen; Weihong Hu; Yan Yao; Mengjie Zhang; YuanMing Wu; Kun Chen
Journal:  Cell Biosci       Date:  2022-07-06       Impact factor: 9.584

2.  Two Chinese siblings of combined oxidative phosphorylation deficiency 14 caused by compound heterozygous variants in FARS2.

Authors:  Liangshan Li; Jianhua Ma; Jingli Wang; Liping Dong; Shiguo Liu
Journal:  Eur J Med Res       Date:  2022-09-26       Impact factor: 4.981

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.